Skip to main content

A Woman with Inexplicable Mood Swings: Patient Management of Premenstrual Syndrome

  • Chapter
  • First Online:
Bio-Psycho-Social Obstetrics and Gynecology

Abstract

Premenstrual disorders are a combination of emotional, behavioral, and physical symptoms that are present in the days prior to and resolve shortly after menses. In some women, the severity of symptoms cause clinically significant distress and interfere with relationships and role functioning. This chapter discusses the definition of premenstrual disorders and how to determine the diagnosis, differential diagnoses, etiopathologic theories, and treatment options including antidepressant medications, hormonal strategies including suppression of ovulation, and nonpharmacological strategies. Both antidepressant medications and hormonal regimens can be considered first-line treatment options; treatment choice is often individually tailored to the woman’s symptoms and preferences.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.

    Book  Google Scholar 

  2. O’Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman E, Halbreich U, Ismail KM, Panay N, Pearlstein T, Rapkin A, Reid R, Schmidt P, Steiner M, Studd J, Yonkers K. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13–21.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200–10.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Steiner M, Li T. Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale. CNS Drugs. 2013;27(8):583–9.

    Article  PubMed  Google Scholar 

  5. Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9(1):41–9.

    Article  CAS  PubMed  Google Scholar 

  6. Steiner M, Streiner DL. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. Can J Psychiatry. 2005;50(6):327–32.

    Article  PubMed  Google Scholar 

  7. Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;(6):CD001396.

    Google Scholar 

  8. Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol. 2008;111(5):1175–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(2):CD006586.

    Google Scholar 

  10. Nevatte T, O’Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundström-Poromaa I, Yonkers K. Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013;16(4):279–91.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM. The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111(6):585–93.

    Article  CAS  PubMed  Google Scholar 

  12. Reid RL. When should surgical treatment be considered for premenstrual dysphoric disorder? Menopause Int. 2012;18(2):77–81.

    PubMed  Google Scholar 

  13. Pearlstein T. Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause Int. 2012;18(2):60–4.

    PubMed  Google Scholar 

  14. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health. 2006;15(1):57–69.

    Article  Google Scholar 

  15. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6(3):203–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Teri Pearlstein MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pearlstein, T., O’Brien, S. (2017). A Woman with Inexplicable Mood Swings: Patient Management of Premenstrual Syndrome. In: Paarlberg, K., van de Wiel, H. (eds) Bio-Psycho-Social Obstetrics and Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-40404-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40404-2_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40402-8

  • Online ISBN: 978-3-319-40404-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics